Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
The review said a certain class of drugs had little [...]
F.D.A. Calls on Drug Developers to Publish Missing Data from Thousands of Trials
Many unfavorable results go unreported, skewing the available data on [...]
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been [...]
La mayoría de los pacientes mantendrían su peso con menos dosis de medicamentos GLP-1
En una investigación reciente, un pequeño grupo de pacientes recibió [...]
F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing [...]
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds
In a recent review, a small group of patients received [...]
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The F.D.A.’s refusal to examine the company’s mRNA shot drew [...]
Some Immune Systems Defeat Cancer. Could That Become a Drug?
Researchers found an antibody that seems to play a role [...]
F.D.A. Approves Wegovy Weight-Loss Pill
The agency greenlit an oral version of the obesity drug [...]
Qué beneficios tiene el CBD
Una encuesta entre 5000 usuarios reveló que más del 60 [...]